Age related macular degeneration and visual disability
- PMID: 20887239
- DOI: 10.2174/138945011794182755
Age related macular degeneration and visual disability
Abstract
Age-related macular degeneration (AMD) is the leading cause of central blindness or low vision among the elderly in industrialized countries. AMD is caused by a combination of genetic and environmental factors. Among modifiable environmental risk factors, cigarette smoking has been associated with both the dry and wet forms of AMD and may increase the likelihood of worsening pre-existing AMD. Despite advances, the treatment of AMD has limitations and affected patients are often referred for low vision rehabilitation to help them cope with their remaining eyesight. The characteristic visual impairment for both forms of AMD is loss of central vision (central scotoma). This loss results in severe difficulties with reading that may be only partly compensated by magnifying glasses or screen-projection devices. The loss of central vision associated with the disease has a profound impact on patient quality of life. With progressive central visual loss, patients lose their ability to perform the more complex activities of daily living. Common vision aids include low vision filters, magnifiers, telescopes and electronic aids. Low vision rehabilitation (LVR) is a new subspecialty emerging from the traditional fields of ophthalmology, optometry, occupational therapy, and sociology, with an ever-increasing impact on the usual concepts of research, education, and services for visually impaired patients. Relatively few ophthalmologists practise LVR and fewer still routinely use prismatic image relocation (IR) in AMD patients. IR is a method of stabilizing oculomotor functions with the purpose of promoting better function of preferred retinal loci (PRLs). The aim of vision rehabilitation therapy consists in the achievement of techniques designed to improve PRL usage. The use of PRLs to compensate for diseased foveae has offered hope to these patients in regaining some function. However, in a recently published meta-analysis, prism spectacles were found to be unlikely to be of substantial benefit in people with age-related macular degeneration. Prescription filters are one of the most beneficial visual aids that people with macular degeneration. In principle, one aims both at reducing short-wavelength light to reduce glare and at identifying light with specific wavelengths (colours) preferred by the patient for viewing. In both instances, such interventions result in apparent improved contrast sensitivity and better visual acuity. Although specific tests are performed to determine the best colour, tint, lens material, and type of frame for the patient's need, no scientific protocol has been developed so far to assist in prescribing tinted or selective transmission lenses . Magnifying optical lenses are available in a wide range of dioptric powers and are made from materials that correct for weight (plastic), thickness (high index), spherical aberrations (aspherical), and variable light intensities (photochromatic). These lenses can be used as loose lenses, mounted on optical frames, or used with a wide variety of attachments. As the dioptric power of plus lenses increases, the viewing distance of the target decreases, hence their usefulness mainly for tasks requiring near resolution acuity, like reading. Magnification can also be achieved with the use of telescopic devices that are built of two or more plus and (or) minus (minifying) optical lenses. Normal resolution acuity levels can be achieved with these devices for all viewing distances. Therefore, all telescopic devices are useful only for stationary patient tasks that do not require mobility and orientation. Electronic magnification has the great advantage over plus lenses of producing an acuity reserve enabling reading skills for almost all levels of visual acuity. The additional benefit provided is preservation of binocularity, even at high levels of visual disparity between the two eyes. Vision rehabilitation can help patients to maximize their remaining vision and adapt to activities of daily living. The support of the patient's social network is critical to patient's well-being as patients adjust to being partially sighted.
Similar articles
-
[Requirements for low vision magnification aids in age-related macular degeneration: Data from the Tübingen low vision clinic (comparison of 2007-2011 with 1999-2005)].Ophthalmologe. 2015 Nov;112(11):923-8. doi: 10.1007/s00347-015-0062-2. Ophthalmologe. 2015. PMID: 26040791 German.
-
Principles of modern low vision rehabilitation.Can J Ophthalmol. 2006 Jun;41(3):289-312. doi: 10.1139/I06-027. Can J Ophthalmol. 2006. PMID: 16767184 Review.
-
[Low vision aids for reading in scar stage of age-related macular degeneration].Nippon Ganka Gakkai Zasshi. 2004 Apr;108(4):202-6. Nippon Ganka Gakkai Zasshi. 2004. PMID: 15148735 Japanese.
-
[Age-related macula degeneration and diabetic retinopathy -- differences in optic rehabilitation].Klin Monbl Augenheilkd. 2005 Apr;222(4):337-41. doi: 10.1055/s-2005-858089. Klin Monbl Augenheilkd. 2005. PMID: 15844045 German.
-
Vision rehabilitation of persons with age related macular degeneration.Semin Ophthalmol. 2011 May;26(3):65-8. doi: 10.3109/08820538.2010.527426. Semin Ophthalmol. 2011. PMID: 21609218 Review.
Cited by
-
VEGF in Tears as a Biomarker for Exudative Age-Related Macular Degeneration: Molecular Dynamics in a Mouse Model and Human Samples.Int J Mol Sci. 2025 Apr 18;26(8):3855. doi: 10.3390/ijms26083855. Int J Mol Sci. 2025. PMID: 40332529 Free PMC article.
-
Evaluating Reading Performance in Different Preferred Retinal Loci in Persian-Speaking Patients with Age-Related Macular Degeneration.J Curr Ophthalmol. 2021 Mar 26;33(1):48-55. doi: 10.4103/JOCO.JOCO_192_20. eCollection 2021 Jan-Mar. J Curr Ophthalmol. 2021. PMID: 34084957 Free PMC article.
-
Usage of brolucizumab as treatment for wet age-related macular degeneration (AMD) and polypoidal choroidal vasculopathy (PCV): A narrative review.Medicine (Baltimore). 2025 Jun 6;104(23):e42666. doi: 10.1097/MD.0000000000042666. Medicine (Baltimore). 2025. PMID: 40489855 Free PMC article. Review.
-
Role of Adiponectin Peptide I (APNp1) in Age-Related Macular Degeneration.Biomolecules. 2022 Sep 3;12(9):1232. doi: 10.3390/biom12091232. Biomolecules. 2022. PMID: 36139070 Free PMC article.
-
Evaluation of vascular endothelial growth factor (VEGF) level in the tears and serum of age-related macular degeneration patients.Sci Rep. 2022 Mar 15;12(1):4423. doi: 10.1038/s41598-022-08492-7. Sci Rep. 2022. PMID: 35292705 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials